Biological assay challenges from compound solubility: strategies for bioassay optimization

Drug Discovery Today
Li Di, E H Kerns

Abstract

Compound solubility in buffers and dimethyl sulfoxide (DMSO) has emerged as an important issue. Many discovery compounds have low solubility but are potentially valuable as leads. Unfortunately, low solubility affects bioassays by causing underestimated activity, reduced HTS-hit rates, variable data, inaccurate SAR, discrepancies between enzyme and cell assays and inaccurate in vitro ADME-Tox testing. Strategies for optimizing bioassays include: considering solubility in HTS-library design; early screening for solubility; improving storage and handling of DMSO stocks; optimizing dilution protocols; and ensuring that low-solubility compounds are fully solubilized in bioassays. These approaches allow for adequate assessments of valuable pharmacophores for which solubility can be chemically optimized at a later date.

References

Aug 26, 2000·Current Opinion in Chemical Biology·R P Hertzberg, A J Pope
Dec 18, 2001·Journal of Pharmaceutical Sciences·E H Kerns
Jan 5, 2002·Journal of Medicinal Chemistry·Olivier RocheGisbert Schneider
Mar 15, 2002·Drug Discovery Today·Paul A Johnston, Patricia A Johnston
Mar 20, 2002·Current Topics in Medicinal Chemistry·A Avdeef
Mar 30, 2002·Advanced Drug Delivery Reviews·William L Jorgensen, Erin M Duffy
Apr 5, 2002·Journal of Medicinal Chemistry·Susan L McGovernBrian K Shoichet
Mar 4, 2003·Nature Reviews. Drug Discovery·Han van de Waterbeemd, Eric Gifford
Apr 2, 2003·Nature Reviews. Drug Discovery·W Patrick Walters, Mark Namchuk
May 6, 2003·Bioorganic & Medicinal Chemistry Letters·Kathryn E S DeanJean-Louis Reymond
Jul 8, 2003·Journal of Biomolecular Screening·Barbara A KozikowskiSandra L Nelson
Jul 8, 2003·Journal of Biomolecular Screening·Barbara A KozikowskiSandra L Nelson
Jul 15, 2003·Journal of Biomolecular Screening·Xueheng ChengRobert Schmitt
Jul 25, 2003·Journal of Medicinal Chemistry·Ali J RyanChun-wa Chung
Mar 10, 2004·Journal of Biomolecular Screening·Konstantin V BalakinAndrey A Ivashchenko
Apr 15, 2004·Drug Discovery Today·Michael Hoever, Peter Zbinden
Apr 29, 2005·Biomolecular Engineering·Marlen Schmidt, Uwe T Bornscheuer
Aug 12, 2005·Journal of Biomolecular Screening·Tudor I OpreaLarry A Sklar
Aug 17, 2005·Journal of Biomolecular Screening·Neil BensonDirk Winkler
Sep 24, 2005·Combinatorial Chemistry & High Throughput Screening·Edward H KernsGuy Carter
Sep 24, 2005·Combinatorial Chemistry & High Throughput Screening·Kevin OldenburgMichele Kelly
Sep 24, 2005·Combinatorial Chemistry & High Throughput Screening·U SchopferP Acklin
Jan 13, 2006·Nature Chemical Biology·Brian Y FengBrian K Shoichet
Dec 1, 2004·Drug Discovery Today. Technologies·E H Kerns, L Di

❮ Previous
Next ❯

Citations

Feb 3, 2009·Analytical and Bioanalytical Chemistry·Yveline HenchozSophie Martel
Jul 14, 2010·Analytical and Bioanalytical Chemistry·Elisa MicheliniAldo Roda
Oct 11, 2007·Journal of Medicinal Chemistry·Lawrence M SzewczukPhilip A Cole
Mar 2, 2011·Nature Reviews. Drug Discovery·M Paul GleesonJohn Overington
Aug 13, 2011·SAR and QSAR in Environmental Research·M HewittT W Schultz
Apr 18, 2012·SAR and QSAR in Environmental Research·K R PrzybylakM Hewitt
Dec 7, 2007·Assay and Drug Development Technologies·Daniel J RodriguesJuha Kammonen
Jul 13, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eric H EklandDavid A Fidock
Mar 14, 2009·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Takashi Mano
Aug 19, 2007·Expert Opinion on Drug Metabolism & Toxicology·Florian NigschSilvia Miret
Jul 1, 2010·Therapeutic Delivery·Evren H GokceEliana B Souto
Aug 9, 2013·Natural Product Reports·Curtis J Henrich, John A Beutler
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kiyohiko Sugano
Oct 6, 2007·Expert Opinion on Drug Metabolism & Toxicology·Jianling WangDejan Bojanic
Jun 1, 2012·Expert Opinion on Drug Discovery·Dino MontanariTino Rossi
Apr 1, 2011·Expert Opinion on Drug Discovery·Kristin Ed CoanMartin Klumpp
Dec 6, 2011·Drug Discovery Today·Li DiTakashi Mano
Jun 7, 2011·Bioorganic & Medicinal Chemistry·Rajarshi GuhaCraig J Thomas
Aug 26, 2014·ACS Medicinal Chemistry Letters·Christos P PapaneophytouGeorge Kontopidis
May 12, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yun W AlelyunasCindy Shen
Aug 15, 2008·Bioorganic & Medicinal Chemistry·Pablo R DuchowiczEduardo A Castro
Jan 22, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bruno BardPierre-Alain Carrupt
Oct 26, 2007·Current Opinion in Biotechnology·Alessio Ciulli, Chris Abell
Jul 3, 2007·Advanced Drug Delivery Reviews·Jochem Alsenz, Manfred Kansy
Sep 27, 2007·Chembiochem : a European Journal of Chemical Biology·Yusuf TanrikuluGisbert Schneider
Apr 20, 2006·International Journal of Pharmaceutics·Li DiSusan L Petusky
Aug 23, 2016·Molecular Informatics·Giuseppe Felice MangiatordiOrazio Nicolotti
Jun 24, 2015·Journal of Molecular Graphics & Modelling·Wilson Maldonado-RojasYovani Marrero-Ponce
Sep 11, 2007·Drug Metabolism and Pharmacokinetics·Kiyohiko SuganoTakashi Mano
Sep 4, 2012·Bioorganic & Medicinal Chemistry·Bryan C DuffyDouglas B Kitchen
Feb 25, 2015·Assay and Drug Development Technologies·Susanna NybondPäivi Tammela
Oct 31, 2013·Dalton Transactions : an International Journal of Inorganic Chemistry·Carolin MüggeWolfgang Weigand
Dec 3, 2014·Methods : a Companion to Methods in Enzymology·Anna Vuorinen, Daniela Schuster
Jan 10, 2013·ACS Medicinal Chemistry Letters·Christos P PapaneophytouGeorge A Kontopidis
Oct 18, 2012·Molecular Pharmaceutics·Florent ChevillardMaria A Miteva
Jan 10, 2008·Journal of Combinatorial Chemistry·John Isbell
Jun 2, 2009·Journal of Biomolecular Screening·William P Janzen, Ioana G Popa-Burke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.